Pharmacodiagnosis Test Targeting Oncology and Neurodegeneration
WO2012127124A1
Tests dedicated to oncology and to neuro-oncology
FR2950075A1
New human LIV21 complex sequences comprising specified nucleotide sequences, small interfering RNA sequence derived from RNA sequences and protein fraction, are protein kinase C epsilon inhibitors useful e.g. to diagnose cancer
FR2950076A1
New human LIV21 complex sequences comprising specified nucleotide sequences, small interfering RNA sequence derived from RNA sequences and protein fraction, are protein kinase C epsilon inhibitors useful e.g. to diagnose cancer
FR2928737A1
Comparing the peptide, antibody or nucleic acid profiles of two cell extract samples comprises using a mixed nucleotide/peptide microarray biochip involving defined amino acid and nucleotide sequences
US2009275020A1
Cellular cycle anomalies for targeting oncology and neurodegeneration
EP2066806A2
Pharmacodiagnostic test targeting oncology and neurodegeneration
EP1869209A2
Traceability of cellular cycle anomalies targeting oncology and neurodegeneration
FR2882753A1
Detecting cancer cells in a sample comprises locating LIV 21 gene expression or increase in protein kinase C expression in cytoplasm
FR2882754A1
Detecting cancer cells for diagnosis of breast cancer, comprises detection of expression differences of protein kinase C epsilon and reduction in association of LIV 21 with E2F4
